Lansforsakringar Fondforvaltning AB publ Makes New $13.99 Million Investment in Axon Enterprise, Inc. (NASDAQ:AXON)

Lansforsakringar Fondforvaltning AB publ purchased a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 23,533 shares of the biotechnology company's stock, valued at approximately $13,986,000.

A number of other large investors have also made changes to their positions in the company. Centaurus Financial Inc. raised its holdings in shares of Axon Enterprise by 43.9% during the fourth quarter. Centaurus Financial Inc. now owns 6,517 shares of the biotechnology company's stock valued at $3,873,000 after acquiring an additional 1,989 shares during the period. Wealthedge Investment Advisors LLC acquired a new stake in shares of Axon Enterprise in the fourth quarter worth $1,677,000. IronOak Wealth LLC. acquired a new stake in shares of Axon Enterprise in the fourth quarter worth $813,000. Siemens Fonds Invest GmbH boosted its position in shares of Axon Enterprise by 219.7% in the fourth quarter. Siemens Fonds Invest GmbH now owns 2,481 shares of the biotechnology company's stock worth $1,475,000 after buying an additional 1,705 shares during the period. Finally, Park Square Financial Group LLC acquired a new stake in shares of Axon Enterprise in the fourth quarter worth $227,000. Institutional investors and hedge funds own 79.08% of the company's stock.

Analysts Set New Price Targets

Several analysts have recently commented on AXON shares. Needham & Company LLC raised their target price on Axon Enterprise from $600.00 to $750.00 and gave the stock a "buy" rating in a research report on Thursday, May 8th. JMP Securities reaffirmed an "outperform" rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Barclays raised their target price on Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a research report on Friday, May 9th. Northcoast Research cut Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 19th. Finally, The Goldman Sachs Group raised their target price on Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a research report on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and ten have assigned a buy rating to the company. According to MarketBeat, Axon Enterprise has a consensus rating of "Moderate Buy" and an average price target of $652.73.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock traded up $13.34 during trading on Friday, reaching $743.63. The company's stock had a trading volume of 1,121,061 shares, compared to its average volume of 732,673. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The business's fifty day moving average price is $620.57 and its 200-day moving average price is $610.60. The firm has a market cap of $57.89 billion, a price-to-earnings ratio of 192.15, a price-to-earnings-growth ratio of 5.17 and a beta of 1.24. Axon Enterprise, Inc. has a one year low of $273.52 and a one year high of $755.05.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, topping analysts' consensus estimates of $1.34 by $0.07. Axon Enterprise had a return on equity of 7.50% and a net margin of 15.37%. The business had revenue of $603.63 million for the quarter, compared to analyst estimates of $585.67 million. During the same period in the previous year, the company posted $1.15 earnings per share. The firm's revenue for the quarter was up 31.3% on a year-over-year basis. As a group, equities research analysts predict that Axon Enterprise, Inc. will post 5.8 earnings per share for the current year.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of the company's stock in a transaction on Monday, April 21st. The stock was sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the transaction, the chief executive officer now owns 3,063,982 shares of the company's stock, valued at approximately $1,657,583,622.18. This represents a 0.33% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jeri Williams sold 307 shares of the company's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now directly owns 1,627 shares in the company, valued at approximately $899,275.44. This represents a 15.87% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 34,969 shares of company stock valued at $23,127,314 in the last three months. 5.70% of the stock is owned by corporate insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.